Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics) - Test2 - elhamkhani - TriplyDB

Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)

Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)

http://www.wikidata.org/entity/Q24610496

about

Animal models of age related macular degeneration Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration [Epidermal aging and anti-aging strategies].p62 provides dual cytoprotection against oxidative stress in the retinal pigment epithelium.Combining nano-physical and computational investigations to understand the nature of "aging" in dermal collagen On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.Why AMD is a disease of ageing and not of development: mechanisms and insights.Nutritional modulation of cataract Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association.Aging and energetics' 'Top 40' future research opportunities 2010-2013.Altered ubiquitin causes perturbed calcium homeostasis, hyperactivation of calpain, dysregulated differentiation, and cataract.How do high glycemic load diets influence coronary heart disease?The mechanism by which moderate alcohol consumption influences coronary heart disease.Synchrotron infrared imaging of advanced glycation endproducts (AGEs) in cardiac tissue from mice fed high glycemic diets.Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets.Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.Nutritional modulation of age-related macular degeneration.How does the macula protect itself from oxidative stress?Dietary glycemia as a determinant of health and longevity Advanced glycation end products: Key players in skin aging?Aging and Autophagy in the Heart Diminishing risk for age-related macular degeneration with nutrition: a current view.Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice.How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body?Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration.Consequences of oxidative stress in age-related macular degeneration.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Common cell biologic and biochemical changes in aging and age-related diseases of the eye: toward new therapeutic approaches to age-related ocular diseases Prevention of protein glycation by natural compounds.EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.Effect of diet-derived advanced glycation end products on inflammation.Glycation in Parkinson's disease and Alzheimer's disease.Methylglyoxal-induced AMPK activation leads to autophagic degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells.Diabetes mellitus and the skin.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Metabolic Effects of High Glycaemic Index Diets: A Systematic Review and Meta-Analysis of Feeding Studies in Mice and Rats.Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.Commentary: Sorbitol treatment extends lifespan and induces the osmotic stress response in Caenorhabditis elegans.Oligomerization with wt αA- and αB-crystallins reduces proteasome-mediated degradation of C-terminally truncated αA-crystallin.

P2860

Q27004686-C2417E1F-7762-43AC-9C0A-8344EAFB34AB Q27012739-9A74DDB8-A22E-4954-AA98-E512E65CFCF1 Q30315912-676692D4-84B2-44AB-8650-D56249017876 Q33603915-11425AF0-33FA-43E0-AE42-981D9563A2AF Q33609992-FB74C346-1FF7-4537-8C48-F40031D9DB95 Q33714263-045E3E9B-D7BF-4995-8327-058B73CD41A4 Q33879659-59D736BA-A524-41D4-856B-ED16A8F588C5 Q33900780-A4476B2D-0C60-480C-88EB-73D1D1E54456 Q33904838-75595EC2-DF11-4BF1-BB88-59259AA5E73E Q33961165-B4DBE451-5A4C-494A-B487-165D434DE226 Q34341924-2492271B-793B-4408-978D-6E7E8585FF5D Q35038062-D208BD54-FF42-4521-B80F-AF3D58EEA987 Q35177141-B48E758A-2DD5-4E47-BA49-20DF279B871D Q35315854-8E0B13CC-2871-4359-8959-7A44984497BD Q35821049-E80596EE-F504-42CB-90AC-C94480C53249 Q35865399-EDA8D0AA-1B78-4D62-88E8-62BC4109876D Q36083881-7EA4DFF6-002D-4947-8BB1-38A00D564B0B Q36083941-D46AE179-DB9D-4EA1-9645-92FEF56B87EE Q36083959-6F1C574A-DB66-446C-AD0B-BCC4756D0DB3 Q36407070-F1B0CDB5-BC45-466A-8D0D-1B94CB2B880A Q36643573-E21FD96E-01D8-4C80-A254-9369C1559D26 Q36909023-6B816788-4449-4B4E-BA8D-A797AD1767B9 Q37083770-E0B82552-0FBE-4DF5-971F-AC09DA558E44 Q37513335-662F1A48-93A9-46C5-9305-9D4F765E20E9 Q37636114-CD6E78EE-CB0B-495B-88A1-A5A270582AAE Q37715254-082DDB0B-2CBF-4E83-9732-E6297CF5E4E4 Q38003229-0A9C20AD-4029-4842-AE66-88BAB255F652 Q38096444-FB0746FA-86B3-49E8-BEBD-BD7842B5AA91 Q38170996-0127FFC3-308F-453C-B112-A38314ED958E Q38358965-3FC973BD-F471-42C6-8F2F-09FAB6336F5F Q38585738-4E528D5F-C188-44CB-A94C-C8158B0BD4FE Q38588208-0F4CB728-502B-425B-9BFF-83D1F6A6AAF4 Q38762228-00B8CECE-F892-4135-B3AD-BB77FC81E3E2 Q38864127-D6FB03A1-8B79-4A94-883F-039A05ECFEB1 Q38901757-FF4A5B0C-1258-46EB-9568-B9675C9B6121 Q39285661-0B246BF8-28E4-444D-93E5-872EB93239B3 Q39390892-9A0FF018-1A0F-416F-8006-C9D47A38DCC0 Q41975515-F4E803A1-A2DF-456E-A09D-04F98AC2CBCA Q42043742-D4F7872A-EE2C-4EC4-9F5F-9D0C60EC7980 Q42176248-DA1F3260-ECE8-4254-88E1-D969B0F82B05

P2860

Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)

http://www.wikidata.org/entity/Q24610496

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@ast

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@en

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@nl

type

label

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@ast

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@en

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@nl

prefLabel

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@ast

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@en

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@nl

P1433

Q24610496-D6D6786A-0E23-4BDA-8F66-C1A7DB56CB63

P1476

Q24610496-4BCB186A-33D3-4E05-AD6B-3508688E9C9A

P2093

Q24610496-11DB5F2A-482F-4CAE-975C-DD029B1A1937

Q24610496-1A10D793-A302-4FB7-9C98-DE43D9008568

Q24610496-2E438A37-29FE-444D-B75A-B4AED867A210

Q24610496-3EF796C9-7A68-466C-A7C6-BAC26DBFD3B4

Q24610496-72DF5F1B-E925-4B87-A2E5-5DFB4F22D04B

Q24610496-CD165566-6D31-488D-94AA-7EAE28C25B5A

Q24610496-CD8339EA-B448-46E5-A205-0A86569CD71D

Q24610496-D756F787-BAA1-4AFF-88DF-F150875C68DA

Q24610496-F873F5A8-2DE3-4D0C-8449-14D3A3A6C5F6

Q24610496-FA17C08D-F166-4A3A-8DC8-23114FFE6A32

P2860

Q24610496-016D491D-D2F5-493B-8843-79EED7E5A7E3

Q24610496-02164139-1FD4-410D-A7B8-1EE10364A718

Q24610496-06E9877B-B08F-40A0-A67E-B2D6341E9A69

Q24610496-07058852-7DBC-444F-A10C-344940D50D34

Q24610496-08A91CB9-BCEC-47E2-952C-6AA9077E9A04

Q24610496-1052C419-A19D-4656-992D-03096BA14A6E

Q24610496-10D70AF5-2228-4ED4-A068-74887B27EB47

Q24610496-13388131-AF5B-4BE8-BA43-517861B8FED1

Q24610496-135B2898-BE2C-40EF-8D83-3DB283548ECF

Q24610496-1B055293-048D-4E43-B7A5-AA5E334FC335

P304

Q24610496-DC570F36-6D12-4397-8476-B2C74CE4EFAE

P31

Q24610496-B03B795B-E4D9-440B-8F48-5A142C868ECA

P356

Q24610496-8B53917C-0BB6-490B-A448-BEFB092E47C1

P407

Q24610496-67B53008-DF6F-4956-A0AD-DA041CA0D1E0

P433

Q24610496-C2BD9391-31AA-4B5D-839D-66F0005CF6D4

P478

Q24610496-26A59393-0C01-4725-BF13-626AF520BE0E

P577

Q24610496-B4EEBD6D-E58E-413F-9E51-DD33CFC84C8E

P5875

Q24610496-FA42DF8E-E9E7-43A3-A72C-9E6841959257

P698

Q24610496-32EFD9A2-4F85-4C36-9620-A877836503E2

P921

Q24610496-79EFC2C2-6CEF-42C5-B4C1-BB3F1859BD17

Q24610496-C1DDB643-85D1-4FB9-9A0B-139658A072C8

P932

Q24610496-0D1B5716-48C8-4E94-A145-C13040FA36F5

P356

J.1474-9726.2011.00752.X

P1433

P1476

Glycation-altered proteolysis ...... ated disease (in nondiabetics)

@en

P2093

Allen Taylor

http://www.w3.org/2001/XMLSchema#string

Andrea Caceres

http://www.w3.org/2001/XMLSchema#string

Dorota Pawlak

http://www.w3.org/2001/XMLSchema#string

Fu Shang

http://www.w3.org/2001/XMLSchema#string

James T Handa

http://www.w3.org/2001/XMLSchema#string

Karen A Weikel

http://www.w3.org/2001/XMLSchema#string

Michael Brownlee

http://www.w3.org/2001/XMLSchema#string

Ram Nagaraj

http://www.w3.org/2001/XMLSchema#string

Tomoaki Uchiki

http://www.w3.org/2001/XMLSchema#string

Wangwang Jiao

http://www.w3.org/2001/XMLSchema#string

P2860

Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas

Informing food choices and health outcomes by use of the dietary glycemic index

Misfolded proteins partition between two distinct quality control compartments

Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy

Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity

Perturbing the ubiquitin pathway reveals how mitosis is hijacked to denucleate and regulate cell proliferation and differentiation in vivo

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1474-9726.2011.00752.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51688997

http://www.w3.org/2001/XMLSchema#string

P698

21967227

http://www.w3.org/2001/XMLSchema#string

P921

P932

3257376

http://www.w3.org/2001/XMLSchema#string